 Warren Cheung
Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 12 | 2024 | 115 | 2.380 |
Why?
| | Rare Diseases | 4 | 2024 | 48 | 1.460 |
Why?
| | Epigenomics | 5 | 2020 | 27 | 0.920 |
Why?
| | Genome, Human | 6 | 2024 | 86 | 0.910 |
Why?
| | Medical Subject Headings | 2 | 2013 | 2 | 0.870 |
Why?
| | Alleles | 4 | 2024 | 214 | 0.850 |
Why?
| | Epigenesis, Genetic | 5 | 2022 | 68 | 0.840 |
Why?
| | Genetic Variation | 6 | 2024 | 174 | 0.800 |
Why?
| | Humans | 28 | 2024 | 6896 | 0.670 |
Why?
| | CpG Islands | 7 | 2022 | 53 | 0.670 |
Why?
| | Genomics | 4 | 2024 | 101 | 0.630 |
Why?
| | High-Throughput Nucleotide Sequencing | 6 | 2023 | 99 | 0.500 |
Why?
| | Drug Design | 2 | 2013 | 7 | 0.470 |
Why?
| | Molecular Sequence Annotation | 2 | 2016 | 9 | 0.460 |
Why?
| | Drug Repositioning | 1 | 2013 | 3 | 0.440 |
Why?
| | Information Storage and Retrieval | 1 | 2013 | 5 | 0.440 |
Why?
| | Periodicals as Topic | 1 | 2013 | 5 | 0.440 |
Why?
| | Disease | 1 | 2013 | 7 | 0.440 |
Why?
| | Genetic Predisposition to Disease | 4 | 2024 | 231 | 0.430 |
Why?
| | Pharmaceutical Preparations | 1 | 2013 | 37 | 0.430 |
Why?
| | Sequence Analysis, DNA | 6 | 2024 | 115 | 0.420 |
Why?
| | Biomedical Research | 1 | 2012 | 27 | 0.410 |
Why?
| | Chromatin | 2 | 2023 | 22 | 0.390 |
Why?
| | Phenotype | 2 | 2024 | 257 | 0.360 |
Why?
| | Metabolic Diseases | 2 | 2019 | 11 | 0.340 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 14 | 0.340 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 117 | 0.320 |
Why?
| | Magnetic Resonance Imaging | 1 | 2009 | 122 | 0.310 |
Why?
| | Vitamin B 12 | 2 | 2017 | 9 | 0.290 |
Why?
| | Computational Biology | 3 | 2013 | 43 | 0.280 |
Why?
| | Haplotypes | 2 | 2024 | 91 | 0.270 |
Why?
| | Female | 11 | 2024 | 3525 | 0.270 |
Why?
| | Base Sequence | 2 | 2023 | 81 | 0.260 |
Why?
| | Male | 10 | 2024 | 3337 | 0.250 |
Why?
| | Adipose Tissue | 3 | 2019 | 27 | 0.250 |
Why?
| | Multifactorial Inheritance | 1 | 2024 | 17 | 0.240 |
Why?
| | Fibroblast Growth Factors | 1 | 2024 | 30 | 0.240 |
Why?
| | T-Lymphocytes | 3 | 2021 | 31 | 0.230 |
Why?
| | Tandem Repeat Sequences | 1 | 2024 | 7 | 0.230 |
Why?
| | Animals | 6 | 2023 | 729 | 0.230 |
Why?
| | Trophoblasts | 1 | 2023 | 16 | 0.220 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 26 | 0.220 |
Why?
| | MEDLINE | 2 | 2013 | 3 | 0.220 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 20 | 0.220 |
Why?
| | Gene Expression Profiling | 3 | 2019 | 126 | 0.220 |
Why?
| | Insurance Coverage | 1 | 2023 | 21 | 0.210 |
Why?
| | Human Growth Hormone | 1 | 2022 | 15 | 0.210 |
Why?
| | Growth Disorders | 1 | 2022 | 25 | 0.210 |
Why?
| | Child | 8 | 2024 | 3364 | 0.200 |
Why?
| | Transcription, Genetic | 3 | 2017 | 44 | 0.200 |
Why?
| | Nasal Mucosa | 1 | 2021 | 8 | 0.200 |
Why?
| | Middle Aged | 5 | 2021 | 608 | 0.190 |
Why?
| | Spermatozoa | 1 | 2020 | 22 | 0.180 |
Why?
| | Neurodevelopmental Disorders | 1 | 2020 | 23 | 0.180 |
Why?
| | Aging | 1 | 2020 | 39 | 0.180 |
Why?
| | Antimicrobial Cationic Peptides | 2 | 2010 | 2 | 0.180 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 31 | 0.180 |
Why?
| | Quantitative Trait Loci | 2 | 2017 | 65 | 0.180 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 101 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 18 | 0.170 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2019 | 7 | 0.170 |
Why?
| | Algorithms | 2 | 2010 | 105 | 0.170 |
Why?
| | Histones | 1 | 2019 | 16 | 0.170 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2019 | 16 | 0.170 |
Why?
| | Glioblastoma | 1 | 2019 | 17 | 0.160 |
Why?
| | Adult | 5 | 2021 | 1181 | 0.160 |
Why?
| | Software | 2 | 2024 | 30 | 0.160 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2019 | 348 | 0.160 |
Why?
| | Brain Neoplasms | 1 | 2019 | 45 | 0.160 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 48 | 0.160 |
Why?
| | Genotype | 2 | 2017 | 410 | 0.160 |
Why?
| | Reproducibility of Results | 2 | 2024 | 199 | 0.150 |
Why?
| | Transcription Factors | 2 | 2023 | 52 | 0.150 |
Why?
| | Aged | 4 | 2020 | 378 | 0.150 |
Why?
| | Repressor Proteins | 1 | 2017 | 12 | 0.150 |
Why?
| | Asthma | 1 | 2020 | 157 | 0.150 |
Why?
| | Chromosomal Position Effects | 1 | 2017 | 3 | 0.150 |
Why?
| | Organ Specificity | 1 | 2017 | 23 | 0.140 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 19 | 0.140 |
Why?
| | Monocytes | 1 | 2016 | 9 | 0.140 |
Why?
| | Neutrophils | 1 | 2016 | 11 | 0.140 |
Why?
| | Immune System Diseases | 1 | 2016 | 6 | 0.140 |
Why?
| | Mice | 4 | 2023 | 348 | 0.140 |
Why?
| | Transcobalamins | 1 | 2016 | 2 | 0.140 |
Why?
| | Cytoplasm | 1 | 2016 | 7 | 0.140 |
Why?
| | Metabolism, Inborn Errors | 1 | 2016 | 6 | 0.140 |
Why?
| | Trans-Activators | 1 | 2016 | 14 | 0.140 |
Why?
| | Gene-Environment Interaction | 1 | 2015 | 13 | 0.130 |
Why?
| | Homeodomain Proteins | 1 | 2015 | 20 | 0.130 |
Why?
| | Genetic Privacy | 1 | 2015 | 2 | 0.130 |
Why?
| | Bone Density | 1 | 2015 | 43 | 0.130 |
Why?
| | Fractures, Bone | 1 | 2015 | 34 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2016 | 115 | 0.120 |
Why?
| | Quantitative Structure-Activity Relationship | 2 | 2010 | 2 | 0.110 |
Why?
| | Genes | 1 | 2012 | 10 | 0.110 |
Why?
| | Databases, Factual | 1 | 2013 | 108 | 0.110 |
Why?
| | Cluster Analysis | 1 | 2012 | 43 | 0.110 |
Why?
| | Mutation | 3 | 2019 | 212 | 0.100 |
Why?
| | Pregnancy | 2 | 2023 | 216 | 0.100 |
Why?
| | Databases, Protein | 1 | 2012 | 2 | 0.100 |
Why?
| | Transcriptome | 2 | 2023 | 59 | 0.100 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 190 | 0.090 |
Why?
| | Peptide Library | 1 | 2010 | 1 | 0.090 |
Why?
| | Microbial Viability | 1 | 2010 | 1 | 0.090 |
Why?
| | Bacteria | 1 | 2010 | 9 | 0.090 |
Why?
| | Cell Differentiation | 2 | 2023 | 59 | 0.090 |
Why?
| | Radionuclide Imaging | 1 | 2009 | 6 | 0.080 |
Why?
| | Pedigree | 2 | 2022 | 59 | 0.080 |
Why?
| | Normal Distribution | 1 | 2009 | 4 | 0.080 |
Why?
| | Dogs | 1 | 2009 | 17 | 0.080 |
Why?
| | Heart | 1 | 2009 | 14 | 0.080 |
Why?
| | Brain | 1 | 2009 | 80 | 0.080 |
Why?
| | Histone Code | 2 | 2019 | 6 | 0.080 |
Why?
| | Fibroblasts | 2 | 2017 | 26 | 0.070 |
Why?
| | Young Adult | 2 | 2021 | 647 | 0.070 |
Why?
| | Twins, Monozygotic | 2 | 2016 | 6 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2009 | 243 | 0.070 |
Why?
| | Penetrance | 1 | 2024 | 8 | 0.060 |
Why?
| | Genetic Loci | 1 | 2024 | 40 | 0.060 |
Why?
| | Infant | 2 | 2021 | 1446 | 0.060 |
Why?
| | Chromosome Mapping | 1 | 2024 | 35 | 0.060 |
Why?
| | Databases, Genetic | 1 | 2024 | 30 | 0.060 |
Why?
| | Cohort Studies | 1 | 2024 | 289 | 0.060 |
Why?
| | Adolescent | 2 | 2021 | 2197 | 0.060 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 14 | 0.060 |
Why?
| | Cell Lineage | 1 | 2023 | 22 | 0.060 |
Why?
| | Placentation | 1 | 2023 | 15 | 0.060 |
Why?
| | Placenta | 1 | 2023 | 21 | 0.060 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 8 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 8 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2022 | 48 | 0.050 |
Why?
| | Genome | 1 | 2022 | 32 | 0.050 |
Why?
| | Immunity, Cellular | 1 | 2021 | 18 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2021 | 16 | 0.050 |
Why?
| | Gene Ontology | 1 | 2020 | 6 | 0.050 |
Why?
| | Germ Cells | 1 | 2020 | 5 | 0.050 |
Why?
| | Fathers | 1 | 2020 | 7 | 0.050 |
Why?
| | Machine Learning | 1 | 2020 | 17 | 0.050 |
Why?
| | Fertility | 1 | 2020 | 18 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2021 | 149 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 99 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2020 | 215 | 0.040 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2020 | 7 | 0.040 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2020 | 11 | 0.040 |
Why?
| | Adipocytes | 1 | 2019 | 3 | 0.040 |
Why?
| | Body Fat Distribution | 1 | 2019 | 4 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2020 | 53 | 0.040 |
Why?
| | Artificial Intelligence | 2 | 2010 | 14 | 0.040 |
Why?
| | Lysine | 1 | 2019 | 3 | 0.040 |
Why?
| | Neurogenesis | 1 | 2019 | 4 | 0.040 |
Why?
| | Methionine | 1 | 2019 | 6 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 7 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 13 | 0.040 |
Why?
| | Lipids | 1 | 2019 | 8 | 0.040 |
Why?
| | Carcinogenesis | 1 | 2019 | 9 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 15 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 32 | 0.040 |
Why?
| | CRISPR-Cas Systems | 1 | 2019 | 13 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2019 | 58 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 59 | 0.040 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 99 | 0.040 |
Why?
| | Obesity | 1 | 2019 | 125 | 0.040 |
Why?
| | Host Cell Factor C1 | 1 | 2017 | 2 | 0.040 |
Why?
| | Zebrafish | 1 | 2017 | 10 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2017 | 5 | 0.040 |
Why?
| | Branchial Region | 1 | 2017 | 7 | 0.040 |
Why?
| | Craniofacial Abnormalities | 1 | 2017 | 10 | 0.040 |
Why?
| | Fetal Blood | 1 | 2016 | 5 | 0.040 |
Why?
| | Alternative Splicing | 1 | 2016 | 18 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2016 | 22 | 0.040 |
Why?
| | Oxidoreductases | 1 | 2016 | 9 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2016 | 35 | 0.030 |
Why?
| | Child, Preschool | 1 | 2021 | 1569 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2016 | 84 | 0.030 |
Why?
| | Twins, Dizygotic | 1 | 2015 | 3 | 0.030 |
Why?
| | Blood | 1 | 2015 | 10 | 0.030 |
Why?
| | Smoking | 1 | 2015 | 22 | 0.030 |
Why?
| | Time Factors | 1 | 2016 | 250 | 0.030 |
Why?
| | Bone and Bones | 1 | 2015 | 17 | 0.030 |
Why?
| | Wnt Proteins | 1 | 2015 | 11 | 0.030 |
Why?
| | Europe | 1 | 2015 | 37 | 0.030 |
Why?
| | Data Anonymization | 1 | 2015 | 2 | 0.030 |
Why?
| | Exome | 1 | 2015 | 36 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2015 | 71 | 0.030 |
Why?
| | Gene Frequency | 1 | 2015 | 90 | 0.030 |
Why?
| | Encyclopedias as Topic | 1 | 2012 | 1 | 0.030 |
Why?
| | Access to Information | 1 | 2012 | 1 | 0.030 |
Why?
| | Internet | 1 | 2012 | 17 | 0.030 |
Why?
| | Rats | 1 | 2012 | 106 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2010 | 7 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 32 | 0.020 |
Why?
| | Pseudomonas | 1 | 2009 | 1 | 0.020 |
Why?
| | Enterobacter cloacae | 1 | 2009 | 1 | 0.020 |
Why?
| | Klebsiella pneumoniae | 1 | 2009 | 2 | 0.020 |
Why?
| | Models, Molecular | 1 | 2009 | 14 | 0.020 |
Why?
| | Enterococcus | 1 | 2009 | 3 | 0.020 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2009 | 11 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2009 | 16 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 33 | 0.020 |
Why?
| | Escherichia coli | 1 | 2009 | 30 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|